Landos Biopharma Inc (LABP)
22.21
-0.26
(-1.16%)
USD |
NASDAQ |
May 20, 16:00
22.21
0.00 (0.00%)
After-Hours: 20:00
Landos Biopharma Price to Book Value: 2.998 for May 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 20, 2024 | 2.998 |
| May 17, 2024 | 3.034 |
| May 16, 2024 | 3.010 |
| May 15, 2024 | 3.010 |
| May 14, 2024 | 3.031 |
| May 13, 2024 | 2.998 |
| May 10, 2024 | 3.015 |
| May 09, 2024 | 3.019 |
| May 08, 2024 | 2.998 |
| May 07, 2024 | 2.993 |
| May 06, 2024 | 2.990 |
| May 03, 2024 | 3.002 |
| May 02, 2024 | 2.997 |
| May 01, 2024 | 3.003 |
| April 30, 2024 | 3.004 |
| April 29, 2024 | 3.028 |
| April 26, 2024 | 3.006 |
| April 25, 2024 | 3.030 |
| April 24, 2024 | 2.988 |
| April 23, 2024 | 2.984 |
| April 22, 2024 | 2.958 |
| April 19, 2024 | 2.940 |
| April 18, 2024 | 2.930 |
| April 17, 2024 | 2.919 |
| April 16, 2024 | 2.899 |
| Date | Value |
|---|---|
| April 15, 2024 | 2.906 |
| April 12, 2024 | 2.899 |
| April 11, 2024 | 2.895 |
| April 10, 2024 | 2.898 |
| April 09, 2024 | 2.894 |
| April 08, 2024 | 2.894 |
| April 05, 2024 | 2.909 |
| April 04, 2024 | 2.894 |
| April 03, 2024 | 2.893 |
| April 02, 2024 | 2.897 |
| April 01, 2024 | 2.908 |
| March 28, 2024 | 2.106 |
| March 27, 2024 | 2.094 |
| March 26, 2024 | 2.114 |
| March 25, 2024 | 2.098 |
| March 22, 2024 | 0.7676 |
| March 21, 2024 | 0.7519 |
| March 20, 2024 | 0.6853 |
| March 19, 2024 | 0.6804 |
| March 18, 2024 | 0.651 |
| March 15, 2024 | 0.651 |
| March 14, 2024 | 0.6353 |
| March 13, 2024 | 0.6353 |
| March 12, 2024 | 0.6402 |
| March 11, 2024 | 0.6127 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1797
Minimum
Apr 13 2023
6.397
Maximum
Nov 09 2021
1.634
Average
0.5934
Median
Price to Book Value Benchmarks
| AbbVie Inc | 36.29 |
| Fusion Pharmaceuticals Inc | 7.573 |
| Masimo Corp | 4.925 |
| Kinnate Biopharma Inc (DELISTED) | 0.7855 |
| Invivyd Inc | 1.504 |
Price to Book Value Related Metrics
| Price | 22.21 |
| Earnings Yield | -17.96% |
| Market Cap | 69.42M |